31 results on '"M. Udovychenko"'
Search Results
2. Implementation of a Facilitative Approach to Teaching Mathematical Disciplines to Future Mathematics Teachers by Means of the MAPLE Package.
- Author
-
I. V. Shyshenko, Ya. O. Chkana, O. V. Martynenko, Olga M. Udovychenko, I. I. Stotskyi, and O. V. Semenikhina
- Published
- 2023
- Full Text
- View/download PDF
3. A Mathematics Teacher's Training to Create a Maker Space in Mathematics Lessons by Means of GeoGebra.
- Author
-
I. V. Shyshenko, O. V. Martynenko, Ya. O. Chkana, Olga M. Udovychenko, T. R. Spas, and O. V. Semenikhina
- Published
- 2022
- Full Text
- View/download PDF
4. The use of electronic textbooks in the learning process: a statistical analysis.
- Author
-
Olga M. Udovychenko, M. M. Ostroha, A. E. Chernysh, O. Yu. Kudrina, Yuliia A. Bondarenko, and A. V. Kurienkova
- Published
- 2020
- Full Text
- View/download PDF
5. Regional Computer Graphics Competition As A Tool Of Influence On The Profession Choice: Experience Of Sumy Region Of Ukraine.
- Author
-
A. O. Yurchenko, Olga M. Udovychenko, A. M. Rozumenko, Ya. O. Chkana, and M. M. Ostroha
- Published
- 2019
- Full Text
- View/download PDF
6. TNF-ALPHA AND SERUM GALECTIN-3 IN NON DIABETIC PATIENTS WITH HEART FAILURE WITH PRESERVED LEFT VENTRICULAR EJECTION FRACTION
- Author
-
A. V. Bolotskykh, Yu. S. Rudyk, M. M. Udovychenko, and T. V. Lozik
- Subjects
Medicine - Abstract
Insulin resistance (IR) leads to structural abnormalities in the heart. Purpose of the study is to investigate the levels of serum Gal-3 levels (sGal3), THF-alpha (TNF-a), Nt-proBNP, HOMA index and insulin and their relationships in non-diabetic patients with heart failure with preserved left ventricular ejection fraction (HFpEF). Forty five non-diabetic patients (27 males and 18 females; mean age 60.4.1±9.7 years) with HFpEF were examined. Patients with diabetes mellitus were excluded. The serum sGal3, TNF-alpha, Nt-proBNP and insulin levels measured in serum by ELISA, according to manufacturer’s instructions. Homeostasis Model Assessment (HOMA) index was calculated as a measure of IR at fasting state (IR=fasting glucose × fasting insulin/22.5).The echocardiographic parameters were measured with M- and B-mode and calculated following the American Guidelines of Echocardiography Society. Continuous variables are expressed as median (25th, 75th percentile). For nonparametric Spearman’s correlation analysis and Mann-Whitney U test were used. All statistical tests were 2-tailed, and p < 0.05 was considered statistically significant. It was found, that IR often occurs in non-diabetic patients with HFpEF. The sGal3, TNF-alpha and insulin are significantly increased in HFpEF patients with IR and without T2DM our study shows an association of the IR, TNF-alpha and sGal3 with echocardiographic parameters in the non diabetic with HFpEF. This fact may indicate the influence of IR on fibrogenesis process and thus facilitate the processes of myocardial remodeling.
- Published
- 2014
7. THE MEDICAL REFORM: REALITIES AND PROSPECTS FOR UKRAINE
- Author
-
Olena G. Rohova, Georgii R. Muratov, Nataliya M. Udovychenko, Zhanna M. Kutuzyan, Ganna Chovpan, Zhanna D. Кravchenkо, and Oleksandr A. Меlnychenko
- Subjects
Globalization ,Public economics ,business.industry ,Technological change ,Urbanization ,Specialization (functional) ,Health care ,Medicine ,Distribution (economics) ,General Medicine ,Integrated approach ,business ,Field (computer science) - Abstract
OBJECTIVE The aim: is to analyze the realities and to determine prospects of the medical reform in Ukraine as a method of public administration of healthcare. PATIENTS AND METHODS Materials and methods: The given paper uses an integrated approach, which consists in the study of public administration of healthcare as a single whole with the coordinated functioning of all its constituents; besides this, the methods, which were used at the empirical and theoretical levels, such as, an abstract logical method, a method of analyses and synthesis, and a method of comparison were applied in the given research. CONCLUSION Conclusions: The medical reform is not a goal in itself, but when implementing the reform, it is necessary to consider other related processes, such as globalization, technological progress, urbanization, demographic crisis, macro-economic situation, unfinished distribution of the rights of property in business, specialization. Now, there is «The Strategy of the Reformation of Healthcare of Ukraine». And the proper use of the complex of methods of public administration, directed both at balanced growth of the national health field, and prevention of negative influence of related sectors and fields of national economy guarantees its successful realization.
- Published
- 2021
8. [CURRENT ISSUES OF BETA-BLOCKERS USE IN THE MANAGEMENT OF COVID-19 (REVIEW)]
- Author
-
M, Udovychenko and I, Rudyk
- Subjects
SARS-CoV-2 ,Adrenergic beta-Antagonists ,COVID-19 ,Humans ,Comorbidity ,Pulmonary Embolism - Abstract
Over the past two decades, the world has witnessed severe acute respiratory syndrome CoV (SARS-CoV), an underlying serious diseases, with a high rate of mortality in patients with comorbidities. Taking into account the clinical features of pulmonary edema, septic shock, deep vein thrombosis and pulmonary embolism, it seems that the severe course of COVID-19 can manifest itself in the body as a sympathetic storm and, possibly, can underlie many of the pathological processes that occur with COVID-19. It is the regulation of the RAAS by the adrenergic system may be crucially important in the course of COVID-19. This article outlines the benefits of beta blockers use in patients with COVID-19 based on the results of recent clinical and epidemiological studies. It has been shown that treatment with beta-blockers in this group of patients can potentially prevent the development of the disease at the earliest stages, reducing morbidity and mortality, preventing or reducing the development of pulmonary embolism, acute respiratory distress syndrome, pulmonary edema and complications of septic shock, fatal rhythm disturbances, etc. Of course, the final conclusions are somewhat premature and further research is needed to assess the positive effects of various beta-blockers use in the treatment of COVID-19.
- Published
- 2021
9. THE MEDICAL REFORM: REALITIES AND PROSPECTS FOR UKRAINE
- Author
-
Oleksandr A, Меlnychenko, Ganna O, Chovpan, Nataliya M, Udovychenko, Georgii R, Muratov, Zhanna D, Кravchenkо, Olena G, Rohova, and Zhanna M, Kutuzyan
- Subjects
Internationality ,Commerce ,Humans ,Ukraine ,Delivery of Health Care - Abstract
The aim: is to analyze the realities and to determine prospects of the medical reform in Ukraine as a method of public administration of healthcare.Materials and methods: The given paper uses an integrated approach, which consists in the study of public administration of healthcare as a single whole with the coordinated functioning of all its constituents; besides this, the methods, which were used at the empirical and theoretical levels, such as, an abstract logical method, a method of analyses and synthesis, and a method of comparison were applied in the given research.Conclusions: The medical reform is not a goal in itself, but when implementing the reform, it is necessary to consider other related processes, such as globalization, technological progress, urbanization, demographic crisis, macro-economic situation, unfinished distribution of the rights of property in business, specialization. Now, there is «The Strategy of the Reformation of Healthcare of Ukraine». And the proper use of the complex of methods of public administration, directed both at balanced growth of the national health field, and prevention of negative influence of related sectors and fields of national economy guarantees its successful realization.
- Published
- 2021
10. POSSIBILITIES OF MODERN X-RAY EXAMINATION METHODS FOR DIAGNOSTICS OF HIDDEN DENTAL CARIES OF APPROXIMAL LOCALIZATION
- Author
-
Tetiana V Tomilina, Iryna I Sokolova, Yuliia O Slynko, Karyna V Skydan, Svitlana I German, Nataliia M Udovychenko, and Anatoliy M. Potapchuk
- Subjects
Molar ,Cone beam computed tomography ,medicine.diagnostic_test ,business.industry ,Dentistry ,Physical examination ,030206 dentistry ,General Medicine ,X ray examination ,Caries lesion ,stomatognathic diseases ,03 medical and health sciences ,0302 clinical medicine ,medicine.anatomical_structure ,stomatognathic system ,Incisor ,030220 oncology & carcinogenesis ,medicine ,Premolar ,Carious lesion ,business - Abstract
OBJECTIVE Introduction: In case of hidden carious cavities development on the approximal teeth surfaces, the clinical diagnostics of this process is difficult. Then, the diagnostics of carious lesion is not possible without carrying out X-ray examination. The aim of the study was a comparative analysis of the effectiveness of clinical and X-ray diagnostics for hidden caries of approximal teeth surfaces. PATIENTS AND METHODS Materials and methods: Condition of 2 963 teeth of 115 people aged from 19 to 55 was analysed. Additionally, a digital panoramic 2D diagnostics (Planmeca ProSensor, Finland) and Cone Beam Computed Tomography 3D Diagnostics (Morita, Japan) were used for clinical examination of patients. RESULTS Results: In both variants of diagnostics, the number of caries defects in the upper jaw was higher than in the lower one, and the frequency of caries lesion of various teeth groups had the following sequence in descending order: molar teeth, premolar teeth, incisor teeth and canine teeth. Hidden carious cavities of average depth and deep were detected with almost the same frequency in both variants of the study, which by 1.9 - 2.0 times respectively exceeded the frequency of superficial carious cavities detection (p = 0.0001). According to the results of clinical studies, hidden superficial carious cavities occurred in single cases and X-ray examination improved their diagnostics by 9.6 times (p = 0.0000). CONCLUSION Conclusions: X-ray examination allows increasing the effectiveness of diagnostics of hidden carious cavities of approximal localization by 1.2 times on the whole (p
- Published
- 2019
11. GENDER ASPECTS OF THE DENTAL STATUS IN THE ADULT POPULATION OF THE KHARKIV REGION
- Author
-
Yu. O. Slynko, I. I. Sokolova, K. I. Karpenko, N. M. Udovychenko, S. I. Herman, T. V. Tomilina, and K. V. Skydan
- Subjects
General Medicine - Published
- 2022
12. Self-incompatibility allele identification in Ukrainian sweet cherry (Prunus avium L.) cultivars
- Author
-
K. M. Udovychenko, N. V. Tryapitsyna, Ya. I. Ivanovych, and R. A. Volkov
- Subjects
Prunus ,Horticulture ,Ukrainian ,language ,food and beverages ,Identification (biology) ,Cultivar ,Allele ,Biology ,language.human_language - Abstract
Aim. Ukrainian breeders have created a large number of sweet cherry cultivars, which still remain almost unexplored at the molecular level. The aim of our study was to identify the self-incompatibility alleles (S-alleles) in Ukrainian sweet cherry cultivars and landraces, and to elucidate, to which cross-incompatibility group the cultivars belong. Methods. The PCR was conducted using consensus primers to the first and second introns of S-RNAse gene and to the single intron of SFB gene. The electrophoretic analysis of the PCR products of the second intron of S-RNAse was carried out in agarose gel, whereas detection of fluorescently labeled DNA fragments of the first S-RNAse intron and the SFB intron was performed using a genetic analyzer. Results. The S-alleles of 25 Ukrainian sweet cherry cultivars and 10 landraces were identified. The S-alleles frequencies and affiliation of cultivars and landraces to the groups of cross-incompatibility were determined. The obtained data can be used in breeding programs and by planning of industrial plantings. Conclusions. In the study, 12 different S-alleles and 79 S-haplotypes were identified. The S1, S3, S4, S5, S6 and S9 alleles are the most widespread among Ukrainian sweet cherry cultivars and landraces. The high frequencies of S5 and especially of S9 alleles are characteristic for the Ukrainian cultivars and distinguish them from other European ones. For the Ukrainian sweet cherry cultivars, the XXXVII (S5S9) cross-incompatibility group appeared to be the most numerous.Keywords: Ukrainian sweet cherry cultivars, S-locus, Sgenotypes, self- and cross-incompatibility, Prunus avium.
- Published
- 2018
13. Review of tools of computer visualization to support educational material
- Author
-
A. O. Yurchenko, O. M. Udovychenko, and D. S. Bezuhlyi
- Subjects
Engineering ,business.industry ,Human–computer interaction ,Applied Mathematics ,business ,Visualization - Published
- 2018
14. ISSR-PCR fingerprinting of Ukrainian sweet cherry (Prunus avium L.) cultivars
- Author
-
Ya. I. Ivanovych, K. M. Udovychenko, M O Bublyk, and R. A. Volkov
- Subjects
0106 biological sciences ,0301 basic medicine ,Genetic diversity ,Ukrainian ,fungi ,food and beverages ,Cell Biology ,Biology ,01 natural sciences ,Agricultural and Biological Sciences (miscellaneous) ,language.human_language ,law.invention ,03 medical and health sciences ,Prunus ,030104 developmental biology ,Genetic marker ,law ,Genetic variation ,Botany ,Genetics ,language ,Cultivar ,Plant breeding ,Polymerase chain reaction ,010606 plant biology & botany - Abstract
ISSR-PCR markers were used to assess genetic diversity and to elucidate relatedness among 21 Ukrainian and 3 West European sweet cherry varieties, which are widely cultivated in Ukraine. The discriminatory potential was tested for 11 ISSR-PCR primers, which produced 193 amplicons. UBC 835, 836, 841 and 881 were identified as the best primers suitable for routine application. The studied cultivars appear to be genetically highly heterogenic and can be divided in two main groups. The first one includes closely related cultivars obtained by hybridization of Drogan’s Yellow (Drogans gelbe Knorpelkirsche), Valerii Chkalov and some other forms. The second group comprises less similar cultivars derived from several West-European and unknown ancestors. Origin of several Ukrainian cultivars is discussed.
- Published
- 2017
15. Association of allele variants of gene Rf with red fruit color of apple cultivars of ukrainian breeding
- Author
-
K. M. Udovychenko, N. Triapitsyna, and Ya. Ivanovych
- Subjects
Horticulture ,Ukrainian ,fungi ,language ,bacteria ,food and beverages ,General Medicine ,Cultivar ,Allele ,Biology ,Gene ,language.human_language - Abstract
Aim. To estimate the possibilities of using the promising apple cultivars, created by the Institute of Horticul- ture (IH) NAAS, in the breeding programs according to the availability of valuable allele variants of gene Rf, related to red color of apple fruit. Methods. Polymerase chain reaction, electrophoresis in agarose gel, the evaluation of phenotype manifestation of the color trait of apple skin according to the grading system. Results. 17 genotypes of apple cultivars of different genetic origin, including 12 cultivars, breeded by IH NAAS, were identifi ed by allele variants of gene Rf. The comparison was made between the genetic analysis results and visual observations of the phenotype manifestation of fruit skin color of different apple cultivars. Conclusions. Apple cultivars Amulet, Perlyna Kyeva and Edera, which are homozygous carriers of dominant alleles А 1 and А 2 of gene Rf are recommended as basic forms in selection programs. It was demonstrated that exact prediction of apple skin color was possible only in case of the available homozygous genotype by both alleles of gene Rf.
- Published
- 2016
16. P322Inhibitors of the renin-angiotensin system in diabetic patients with heart failure with preserved ejection fraction treatment: impact of m235t polymorphism of angiotensinogen
- Author
-
I. Rudyk, I. Gasanov, M M Udovychenko, T G Ovrakh, D. Babichev, S N Pyvovar, O Medentseva, and Galchinska
- Subjects
Ramipril ,medicine.medical_specialty ,Ejection fraction ,Angiotensin Receptor Antagonists ,biology ,business.industry ,Angiotensin-converting enzyme ,medicine.disease ,Valsartan ,Internal medicine ,Heart failure ,Renin–angiotensin system ,biology.protein ,Cardiology ,Medicine ,Cardiology and Cardiovascular Medicine ,business ,Heart failure with preserved ejection fraction ,medicine.drug - Abstract
Background Inhibitors of the renin-angiotensin system plays an important role in chronic heart failure treatment. However, the impact of Angiotensin-converting enzyme (ACE) inhibitors and Angiotensin II receptor blockers (ARBs) on treatment efficacy in diabetic patients with heart failure with preserved preserved ejection fraction (HFpEF) depending on M235T polymorphism of ATG is still unknown. Aim To estimate the efficacy of ACE inhibitors and ARBs therapy in diabetic patient with HFpEF depending on the polymorphism of the M235T of the ATG gene. Methods A total of eighty-two patients (50 females and 32 males; mean age 62,9±8,1 years) with HFpEF and type 2 diabetes mellitus were examined. Sixty-two patients were carriers of 235T allele (MT+TT genotypes), 20 patients had MM genotype of M235T polymorphism of ATG, which was determined by using of polymerase chain reaction. All patients were divided into 4 groups depending on genotypes taking Ramipril or Valsartan during 12 months. Clinical examination, 6 minute walking test, Minnesota Living with Heart Failure Questionnaire (MLHFQ) have been used. All statistical tests were 2-tailed and p Results It was not found the significant difference in efficacy of treatment using Valsartan or Ramipril in diabetic patients with genotype MM with HFpEF, whereas in the presence of the T allele of the polymorphism of the M235T ATG, use of valsartan was more effective. Table shows the dynamics of the investigated parameters. Dynamics of parametrs during treatment Parameters HFpEF and DM2T, TT or MT HFpEF and DM2T, MM Ramipril (n=22) Valsartan (n=21) Ramipril (n=10) Valsartan (n=10) Baseline After 12 months treatment Baseline After 12 months treatment Baseline After 12 months treatment Baseline After 12 months treatment SBP, mm Hg 172.0 [157.2; 178.5] 150.0 [132.0; 152.0]* 165.0 [145.3; 174.2] 128.0 [126.0; 134.0]* 167,5 [152.5; 176.0] 140.0 [134.0; 142.0] 160,0 [144.0; 170.0] 146.0 [138.0; 150.0] DBP, mm Hg 98.0 [86.0; 104.0] 92.0 [80.0; 94.0]* 96.0 [82.0; 100.0] 86.0 [80.0; 88.0]* 102.0 [84.0; 106.0] 98.0 [84.0; 100.0] 99.0 [80.0; 100.0] 94.0 [80.0; 96.0] 6 min test, m 313,0 [226,7; 375,5] 320,0 [236,4; 384,6]* 342.5 [258.0; 393.7] 372,0 [262,7; 397,9]* 305.0 [190.5; 375.0] 315.0 [198.5; 384.0] 328.0 [295.0; 401.0] 342.0 [298.0; 410.0] MLHFQ 62,0 [50,0; 71,2] 56,0 [46,5; 68,4]* 61.5 [50.5; 71.5] 40.5 [36.5; 56.5]* 60.0 [47.0; 76.2] 54.0 [43.0; 70.0] 58.0 [49.5; 76.2] 58.0 [49.5; 76.2] Dispnea, % 100 90* 100 70* 100 90 100 80 Edema, % 68,1 54,5* 61,9 33,3* 50 40 60 60 SBP, systolic blood pressure; DBP, diastolic blood pressure; MLHFQ, Minnesota Living with Heart Failure Questionnaire; statistically significant changes (p Conclusion Use of Valsartan comparing to Ramipril in diabetic T allele carriers of M235T polymorphism of ATG with HFpEF was independently associated with more effective clinical signs of heart failure improvement, blood pressure decrease, quality of life according to the MLHFQ and physical activity tolerance increase.
- Published
- 2019
17. Possibilities of modern x-ray examination methods for diagnostics of hidden dental caries of approximal localization
- Author
-
Iryna I, Sokolova, Svitlana I, German, Tetiana V, Tomilina, Yuliia O, Slynko, Anatoliy M, Potapchuk, Karyna V, Skydan, and Nataliia M, Udovychenko
- Subjects
Adult ,Cuspid ,Young Adult ,Adolescent ,X-Rays ,Humans ,Cone-Beam Computed Tomography ,Dental Caries ,Middle Aged - Abstract
Introduction: In case of hidden carious cavities development on the approximal teeth surfaces, the clinical diagnostics of this process is difficult. Then, the diagnostics of carious lesion is not possible without carrying out X-ray examination. The aim of the study was a comparative analysis of the effectiveness of clinical and X-ray diagnostics for hidden caries of approximal teeth surfaces.Materials and methods: Condition of 2 963 teeth of 115 people aged from 19 to 55 was analysed. Additionally, a digital panoramic 2D diagnostics (Planmeca ProSensor, Finland) and Cone Beam Computed Tomography 3D Diagnostics (Morita, Japan) were used for clinical examination of patients.Results: In both variants of diagnostics, the number of caries defects in the upper jaw was higher than in the lower one, and the frequency of caries lesion of various teeth groups had the following sequence in descending order: molar teeth, premolar teeth, incisor teeth and canine teeth. Hidden carious cavities of average depth and deep were detected with almost the same frequency in both variants of the study, which by 1.9 - 2.0 times respectively exceeded the frequency of superficial carious cavities detection (p = 0.0001). According to the results of clinical studies, hidden superficial carious cavities occurred in single cases and X-ray examination improved their diagnostics by 9.6 times (p = 0.0000).Conclusions: X-ray examination allows increasing the effectiveness of diagnostics of hidden carious cavities of approximal localization by 1.2 times on the whole (p0,05). In such cases orthopantomography (OPG) has reasonably sufficient diagnostic capabilities. Definitely, 3D Cone Beam Computed Tomography (CBCT) has much more diagnostic capabilities, but its use can not be justified for the diagnostics of caries only.
- Published
- 2019
18. ASSOCIATION BETWEEN TUMOR NECROSIS FACTOR, BRAIN NATRIURETIC PEPTIDE AND POLYMORPHISM OF THE M235T OF THE ATG GENE IN HYPERTENSIVE PATIENTS WITH HEART FAILURE
- Author
-
I. Gasanov, V. Galchinskaya, O Medentseva, M M Udovychenko, I. Rudyk, D. Babichev, and T G Ovrakh
- Subjects
medicine.medical_specialty ,Physiology ,business.industry ,Brain natriuretic peptide ,medicine.disease ,Endocrinology ,Polymorphism (computer science) ,Internal medicine ,Heart failure ,Internal Medicine ,medicine ,Tumor necrosis factor alpha ,Cardiology and Cardiovascular Medicine ,business ,Gene - Published
- 2021
19. CERTAIN STRUCTURAL CHARACTERISTICS OF DENTISHION SMALL DEFECTS IN THE ADULT POPULATION OF KHARKIV
- Author
-
I. I. Sokolova, V. V. Oleynichuk, Yu. O. Slynko, and N. M. Udovychenko
- Subjects
Adult population ,Biology ,Demography - Published
- 2021
20. Association of tumor necrosis factor-alpha and lipid parameters in patients with coronary heart disease and heart failure
- Author
-
V. Galchinskaya, O Medentseva, I. Gasanov, M. Udovychenko, I. Rudyk, and D. Babichev
- Subjects
medicine.medical_specialty ,business.industry ,Heart failure ,Internal medicine ,medicine ,Cardiology ,Tumor necrosis factor alpha ,In patient ,Cardiology and Cardiovascular Medicine ,medicine.disease ,business ,Coronary heart disease - Published
- 2020
21. P6523M235T polymorphism of ATG: prognostic marker of cardiovascular events in diabetic patients with heart failure with preserved ejection fraction, a 2 year follow-up
- Author
-
I. Rudyk, M M Udovychenko, T. V. Lozyk, I G Kravchenko, S N Pivovar, T N Bondar, Ganna Bolotskykh, O Medentseva, and T G Ovrakh
- Subjects
medicine.medical_specialty ,business.industry ,Internal medicine ,medicine ,Cardiology ,Cardiology and Cardiovascular Medicine ,Heart failure with preserved ejection fraction ,business - Published
- 2018
22. P6522Prognostic value of st2 in diabetic patients with heart failure and preserved ejection fraction
- Author
-
I. Rudyk, Tatyana Lozyk, Ganna Bolotskykh, O Medentseva, I G Kravchenko, S N Pivovar, L L Pietienova, T G Ovrakh, and M M Udovychenko
- Subjects
medicine.medical_specialty ,Ejection fraction ,business.industry ,Heart failure ,Internal medicine ,Cardiology ,Medicine ,Cardiology and Cardiovascular Medicine ,business ,medicine.disease ,Value (mathematics) - Published
- 2018
23. Clinical and biochemical predictors of unfavorable prognosis for heart failure with preserved ejection fraction and type 2 diabetes mellitus
- Author
-
Iurii Rudyk, Ganna Bolotskykh, and Maryna M. Udovychenko
- Subjects
medicine.medical_specialty ,business.industry ,Internal medicine ,Cardiology ,Medicine ,Type 2 Diabetes Mellitus ,General Medicine ,Heart failure with preserved ejection fraction ,business - Published
- 2015
24. PREDICTION MODEL FOR CARDIOVASCULAR EVENTS IN HYPERTENSIVE PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION AND TYPE 2 DIABETES MELLITUS
- Author
-
S. M. Pyvovar, V. Galchinskaya, O Medentseva, I. Rudyk, I. Gasanov, M M Udovychenko, and T G Ovrakh
- Subjects
medicine.medical_specialty ,Physiology ,business.industry ,Internal medicine ,Diagnostic model ,Internal Medicine ,Cardiology ,medicine ,Type 2 Diabetes Mellitus ,Stage (cooking) ,Cardiology and Cardiovascular Medicine ,business ,Heart failure with preserved ejection fraction - Abstract
Objective:To develop diagnostic model of negative cardiovascular events prediction in hypertensive patients with chronic heart failure with preserved ejection fraction (HFpEF) and type 2 diabetes mellitus (DM).Design and method:A total of eighty-three hypertensive patients (II –III stage) with HFpEF
- Published
- 2019
25. Poster session 1
- Author
-
J. Schlueter, T. Brand, D. J. Henderson, V. Boczonadi, P. Humbert, B. Chaudhry, D. Sedmera, J. Svatunkova, R. Kockova, B. Sankova, C. Lopez Sanchez, D. Franco, A. Aranega, V. Garcia-Martinez, E. Demina, V. Miroshikova, A. Denisenko, A. Schwarzman, F. Sanchez-Cabo, C. Torroja, A. Benguria, R. Buchan, P. Srivastava, F. Martinez, P. Barton, S. Cook, A. Dopazo, E. Lara-Pezzi, H. Rai, S. Kumar, A. K. Sharma, S. Mastana, A. Kapoor, C. M. Pandey, S. Agrawal, N. Sinha, J. Lipkova, M. Goldbergova, J. Parenica, J. Bienertova Vasku, A. Vasku, P. Kala, J. Spinar, L. Perez-Cabornero, D. Cantalapiedra, A. Forteza, R. Saez-Villaverde, J. Zumalde, V. Fernandez-Pedrosa, S. Zuniga-Trejos, M. Gil-Borja, M. Lazaro, S. Santillan, M. Costa, N. Cortez-Dias, P. Carrilho-Ferreira, D. Silva, C. Jorge, R. Placido, C. Calisto, M. Fiuza, A. Nunes Diogo, F. J. Enguita, H. H. W. Sillje, B. Lu, H. Yu, M. Zwartbol, W. P. Ruifrok, W. H. Van Gilst, R. A. De Boer, D. Zaliaduonyte-Peksiene, S. Simonyte, V. Lesauskaite, J. Vaskelyte, V. Mizariene, R. Zaliunas, W. Tigchelaar, E. Barlaka, A. Lazou, C. Del Giudice, E. Cipolletta, A. Anastasio, G. Santulli, M. Rusciano, A. S. Maione, P. Campiglia, M. Illario, B. Trimarco, G. Iaccarino, G. A. Frentzou, M. J. Drinkhill, N. A. Turner, S. G. Ball, J. F. X. Ainscough, L. Bertrand, F. Mailleux, J. Hammond, A. Ginion, L. Hue, J. L. Balligand, S. Horman, J. L. Vanoverschelde, C. Beauloye, B. Demeulder, S. L. Puhl, A. Mueller, Y. Devaux, D. R. Wagner, K. Roemer, M. Boehm, C. Maack, D. Miranda-Silva, I. Falcao-Pires, N. Goncalves, D. Moreira-Goncalves, A. F. Leite-Moreira, F. Mraiche, L. Fliegel, J. Xue, G. G. Haddad, L. C. Hsiao, C. Carr, Z. F. Cui, K. Clarke, M. A. D'amico, P. Izzicupo, A. Di Fonso, A. Bascelli, S. Gallina, A. Di Baldassarre, C. Silvestre, P. Fernandez, O. M. Pello, C. Indolfi, F. Civeira, R. Hutter, B. Ibanez, J. Chaves, J. Martinez-Gonzalez, V. Andres Garcia, A. Zabirnik, N. Smolina, A. Malashicheva, E. Omelchenko, T. Sejersen, A. Kostareva, C. Noack, M. P. Zafiriou, A. Renger, R. Dietz, H. J. Schaeffer, M. B. Bergmann, C. Zelarayan, S. Van Linthout, K. Miteva, M. P. Becher, M. Haag, J. Ringe, H.-P. schultheiss, M. Sittinger, C. Tschoepe, T. Kakuchaya, L. Bockeria, E. Golukhova, M. Eremeeva, N. Chigogidze, I. Aslanidi, I. Shurupova, A. Svobodov, A. A. Ramkisoensing, D. A. Pijnappels, J. Swildens, M. J. Goumans, M. J. Schalij, A. A. F. De Vries, D. E. Atsma, A. Gomes, G. M. Costa, C. A. Cordeiro, A. Matsuada, L. B. Rosario, A. P. Freire, M. Bousquenaud, M. Rolland-Turner, F. Maskali, L. Zhang, P. Y. Marie, F. Azuaje, A. J. Smith, G. M. Ellison, C. D. Waring, S. Purushothaman, D. Torella, B. Nadal-Ginard, M. H. Van Marion, D. W. J. Van Der Schaft, M.-J. Goumans, F. P. T. Baaijens, C. V. C. Bouten, N. Kraenkel, K. Kuschnerus, M. Mueller, T. Speer, S. Briand, M. Bader, P. Madeddu, T. F. Luescher, U. Landmesser, A. Papalamprou, C. Vicinanza, D. F. Goldspink, M. Noseda, S. J. Mcsweeney, T. Leja, E. Belian, I. Macaulay, F. Al-Beidh, S. Koenemann, M. S. Abreu Pavia, S. E. Jacobsen, M. D. Schneider, G. Foldes, Z. Bagyura, Z. Lendvai, D. Mathe, T. Nemeth, J. Skopal, I. Foldes, B. Merkely, S. E. Harding, A. J. Candasamy, R. S. Haworth, A. Boguslavsky, F. Cuello, M. J. Shattock, M. Mayr, M. Gautel, M. Avkiran, P. Leszek, B. Sochanowicz, M. Szperl, P. Kolsut, K. Brzoska, W. Piotrowski, T. Rywik, B. Danko, J. Rozanski, M. Kruszewski, N. Bouteldja, R. J. Woodman, C. L. Hewitson, E. Domingo, J. A. Barbara, A. A. Mangoni, R. Carnicer Hijazo, A. B. Hale, X. Liu, S. Suffredini, J. K. Bendall, G. B. S. Lim, N. J. Alp, K. M. Channon, B. Casadei, L. R. Moltzau, J. M. Aronsen, S. Meier, I. Sjaastad, T. Skomedal, J.-B. Osnes, F. O. Levy, E. Qvigstad, P. T. Wright, L. M. K. Pannell, A. R. Lyon, J. Gorelik, A. Guellich, S. F. Vatner, R. Fischmeister, B. Manoury, E. Dubois, J. Hamelet, A. Vanderper, P. Herijgers, D. Langin, F. Gartner, J. Gummert, H. Milting, G. Euler, M. Priess, J. Heger, T. Noll, R. Schulz, T. Doi, T. Akagami, T. Naka, T. Masuyama, M. Ohyanagi, M. Massaro, E. Scoditti, M. Pellegrino, M. A. Carluccio, C. Martines, C. Storelli, R. De Caterina, M. Falck-Hansen, M. E. Goddard, J. E. Cole, N. Astola, A. J. Cross, R. Krams, C. Monaco, M. F. Corsten, W. Verhesen, A. P. Papageorgiou, P. Carai, M. Lindow, S. Obad, G. Summer, L. De Rijck, S. Coort, M. Hazebroek, R. Van Leeuwen, M. Gijbels, M. P. J. De Winther, F. R. M. Stassen, S. Kauppinen, B. Schroen, S. Heymans, Z. Husti, V. Juhasz, L. Virag, A. Kristof, I. Koncz, T. Szel, I. Baczko, N. Jost, J. G. Y. Papp, A. Varro, A. Ghigo, A. Perino, F. Damilano, J. Leroy, V. O. Nikolaev, W. Richter, M. Conti, G. Vandecasteele, E. Hirsch, R. Ang, S. Sebastian, A. Ludwig, L. Birnbaumer, A. Tinker, E. A. Ertel, R. Sube, A. Opel, C. L-H Huang, A. Grace, N. Tribulova, J. Radosinska, B. Bacova, T. Benova, V. Knezl, J. Slezak, T. A. Matsuyama, T. Tanaka, T. Adachi, Y. Jiang, H. Ishibashi-Ueda, T. Takamatsu, J. Kornej, C. Reihardt, J. Kosiuk, A. Arya, G. Hindricks, V. Adams, D. Husser, A. Bollmann, S. Severi, M. Fantini, E. Ravagli, L. A. Charawi, D. Difrancesco, C. Poulet, L. Lu, U. R. Ravens, M. Hoch, T. Koenig, A. Gardiwal, B. Stapel, S. Erschow, A. Froese, B. Weinhold, R. Gerardy-Schahn, G. Klein, D. Hilfiker-Kleiner, K. Chinda, S. Palee, S. Surinkaew, M. Phornphutkul, S. Chattipakorn, N. Chattipakorn, B. Tuana, Z. Kohajda, A. A. Kristof, C. Corici, F. Fulop, N. L. Jost, V. Szuts, D. Menesi, G. L. Puskas, A. Zvara, N. Houshmand, J. G. Papp, N. Al-Shanti, M. Hancock, A. Venturini, C. Stewart, R. Ascione, G. Angelini, M.-S. Suleiman, A. Gonzalez-Tendero, I. Torre, F. Crispi, E. Gratacos, T. Tzanavari, E. Varela, A. Economides, S. Theocharis, C. Pantos, D. V. Cokkinos, A. Karalis, P. Hecker, V. Lionetti, W. C. Stanley, C. Ferrara, N. Piroddi, B. Scellini, C. Ferrantini, V. Sequiera, C. Remedios, L. Carrier, C. Tesi, J. Van Der Velden, C. Poggesi, V. Kooij, G. J. M. Stienen, D. Dooijes, s. Marston, C. Redwood, C. Dos Remedios, I. Diakonov, S. Tokar, M. Sikkel, S. Schlossarek, M. Sauer, A. Papageorgiou, S. Velthuis, E. Lutgens, M. Swinnen, N. Van Rooijen, J. Kzhyshkowska, P. Carmeliet, P. Garcia-Canadilla, F. Garcia-Garcia, I. Iruretagoiena, J. Dopazo, I. Amat-Roldan, M. H. Zhang, Y. H. Zhang, C. E. Sears, B. Wojtas, A. Llach, L. Hove-Madsen, V. Spinelli, L. Sartiani, M. Bucciantini, R. Coppini, E. Russo, A. Mugelli, E. Cerbai, M. Stefani, M. Ibrahim, P. Kukadia, M. Navaratnarajah, U. Siedlecka, C. Van Doorn, M. Yacoub, C. Terracciano, W. Song, N. Curtin, R. Woledge, S. Marston, M. Balteau, N. Tajeddine, G. Behets-Wydemans, C. Dessy, P. Gailly, W. J. Van Der Laarse, S. J. P. Bogaards, D. Van Groen, Y. Y. Wong, I. Schalij, A. Vonk Noordegraaf, F. M. Faz, B. Littlejohns, P. Pasdois, A. P. Halestrap, G. D. Angelini, S. Lemoine, V. Jaspard-Vinassa, F. Vigneron, P. Dos Santos, M. Popescu, A. Vlad, G. Isvoranu, L. Suciu, B. Marinescu, D. Dimulescu, L. Zagrean, P. W. M. Kleikers, K. Wingler, K. Radermacher, A. Sydykov, H. A. Ghofrani, N. Weissmann, H. H. W. Schmidt, A. Poddubnaya, K. E. M. Khurs, S. O. G. Smolenskaya, G. Szucs, Z. Murlasits, S. Torok, G. F. Kocsis, T. Csont, C. Csonka, P. Ferdinandy, R. Dongworth, D. M. Yellon, D. J. Hausenloy, Y. Y. Chen, W. S. Lian, C. F. Cheng, K. H. Khoo, T. C. Meng, G. Youcef, E. Belaidi, L. Fazal, M. P. Vinvent, D. De Paulis, G. Zadigue, C. Richer-Giudicelli, F. Alhenc-Gelas, M. Ovize, A. Pizard, R. Cal, J. Castellano, J. Farre, G. Vilahur, L. Badimon, V. Llorente-Cortes, H. Naz, M. Gharanei, C. Mee, H. Maddock, A. Hussain, O. Pisarenko, V. Shulzhenko, L. Serebryakova, I. Studneva, Y. Pelogeykina, D. Khatri, O. Tskitishvili, E. Barnucz, G. Veres, P. Hegedus, T. Radovits, S. Korkmaz, S. Klein, R. Zoller, M. Karck, G. Szabo, S. Morel, M. A. Frias, C. Rosker, R. W. James, S. Rohr, B. R. Kwak, V. Braunersreuther, B. Foglia, F. Mach, E. Shantsila, S. Montoro-Garcia, L. D. Tapp, S. Apostolakis, B. J. Wrigley, G. Y. H. Lip, E. Sokolowska, K. Przyborowski, K. Kramkowski, W. Buczko, A. Mogielnicki, U. Simonsen, E. R. Hedegaard, B. D. Nielsen, A. Kun, A. Hughes, C. Kroigaard, S. Mogensen, O. Frobert, K. Ait Aissa, J. P. Max, D. Wahl, T. Lecompte, P. Lacolley, V. Regnault, A. Novakovic, M. Pavlovic, A. Vranic, P. Milojevic, I. Stojanovic, M. Jovic, D. Nenezic, N. Ugresic, Q. Yang, G. W. He, L. Calvier, P. Reboul, B. Martin-Fernandez, V. Lahera, F. Zannad, V. Cachofeiro, P. Rossignol, N. Lopez-Andres, V. K. Pulakazhi Venu, R. Baetta, A. Bonomo, A. F. Muro, A. Corsini, A. L. Catapano, G. D. Norata, L. E. Viiri, L. E. Full, T. J. Navin, A. Didangelos, I. Seppala, T. Lehtimaki, A. H. Davies, R. Wait, D. Sedding, P. Stieger, C. Thoelen, S. Fischer, J. M. Daniel, R. Widmer-Teske, K. T. Preissner, N. Alenina, L. A. Rabelo, M. Todiras, V. N. Souza, J. M. Penninger, R. A. Santos, I. A. Leonova, S. A. Boldueva, V. S. Feoktistova, O. V. Sirotkina, M. G. Kolesnichenko, Z. Springo, P. Toth, P. Cseplo, G. Szijjarto, A. Koller, S. Puthenkalam, M. K. Frey, I. M. Lang, R. Madonna, H. Shelat, Y. J. Geng, T. Ziegler, V. Pfetsch, J. Horstkotte, C. Schwab, I. Rohwedde, R. Hinkel, Q. Di, S. Dietzel, U. Deutsch, C. Kupatt, I. Ernens, B. Lenoir, O. Fortunato, A. Caporali, E. Sangalli, D. Cordella, M. Marchetti, G. Spinetti, C. Emanueli, G. Arderiu, E. Pena, M. J. Forteza, V. Bodi, S. Novella, C. Alguero, I. Trapero, I. Benet, C. Hermenegildo, J. Sanchis, F. J. Chorro, A. Nemeth, S. Szabados, A. Cziraki, E. Sulyok, I. G. Horvath, M. Rauh, W. Rascher, I. Sikharulidze, I. B. Bakhlishvili, J. T. T. Laitinen, J. P. Hytonen, O. Leppanen, J. Taavitsainen, A. Partanen, P. Korpisalo, S. Yla-Herttuala, J. Lonn, J. Hallstrom, T. Bengtsson, M. C. Guisasola, E. Dulin, S. Stojkovic, C. Kaun, G. Maurer, K. Huber, J. Wojta, S. Demyanets, T. B. Opstad, A. Pettersen, S. Aakra, H. Arnesen, I. Seljeflot, M. Borrell-Pages, C. Romero, A. Toso, M. Leoncini, L. Tanini, T. Pizzetti, F. Tropeano, M. Maioli, P. Casprini, F. Bellandi, R. F. Antunes, J. C. Kaski, I. E. Dumitriu, E. Wu, A. A. L. Tareen, M. Udovychenko, I. Rudyk, K. Riches, L. Franklin, A. Maqbool, J. Bond, M. L. Koschinsky, D. J. O'regan, K. E. Porter, I. R. Parepa, A. I. Suceveanu, A. Suceveanu, L. Mazilu, L. Cojocaru, A. Rusali, L. A. Tuta, E. Craiu, D. Lindner, C. Zietsch, H.-P. Schultheiss, C. Tschope, D. Westermann, M. Miana, E. Martinez, R. Jurado, C. Delgado, N. Gomez-Hurtado, A. Briones, J. Young, T. J. Geng, A. Brodehl, T. Schmidt, O. Smolenskaya, C. Stegemann, D. Byzov, I. Mikhaylova, N. Chizh, E. Pushkova, O. Synchykova, B. Sandomirsky, O. Freylikhman, O. Rotar, N. Chromova, E. Moguchaya, V. Ivanenko, E. Kolesova, A. Erina, M. Boyarinova, A. Konradi, S. D. Preston, D. Baskaran, A. M. Plonczak, K. Norita, S. V. De Noronha, M. N. Sheppard, A. Haghikia, S. F. Hill, M. Hoepfner, B. Nitzsche, M. Schrader, F. Zengerling, B. Hoffmann, A. Pries, S. Gao, J. T. Laitinen, S. Laidinen, H. Markkanen, H. Karvinen, V. Marjomaki, I. Vajanto, T. T. Rissanen, K. Alitalo, P. Mello Ferrao, M. C. Waghabi, L. R. Garzoni, J. Ritterhoff, C. Weidenhammer, M. Voelkers, W. H. Zimmermann, J. Rabinowitz, P. Most, S. C. Gordts, I. Muthuramu, F. Jacobs, E. Van Craeyveld, E. Nefyodova, B. De Geest, D. R. Tribuddharat, D. R. Sathitkarnmanee, M. R. Buddhisa, M. S. Suwannasaen, D. R. Silarat, D. R. Ngamsangsirisup, D. R. Hawrylowicz, D. R. Lertmemongkolchai, S. Rain, M. L. Handoko, N. Westerhof, A. Vonk-Noordegraaf, F. S. De Man, A. S. Iakovleva, O. A. Mirolyubova, A. Berezin, T. A. Samura, Suwannasaen, Tippayawat, Ngamsangsirisup, D. R. Sutra, Hawrylowicz, Lertmemongkolchai, L. M. Lima, M. G. Carvalho, D. R. G. Junqueira, M. O. Sousa, A. Zampetaki, P. Willeit, L. Tilling, I. Drozdov, M. Prokopi, A. Shah, C. Boulanger, P. Chowienczyk, S. Kiechl, S. H. V. Oliveira, V. Kirillova, E. Prosviryakov, C. T. M. Van Der Pouw Kraan, F. J. P. Bernink, J. M. Baggen, L. Timmers, A. M. Beek, M. Diamant, A. C. Van Rossum, N. Van Royen, A. J. G. Horrevoets, J. E. A. Appelman, A. Zyatenkov, L. S. Kokov, Y. U. D. Volynskiy, M. Krestjyaninov, V. I. Ruzov, A. V. Villar, E. Martinez-Laorden, A. Almela, M. A. Hurle, M. L. Laorden, N. Apaijai, M. K. Mcmullen, J. M. Whitehouse, G. Shine, and A. Towell
- Subjects
Gerontology ,Physiology ,business.industry ,Physiology (medical) ,Cancer research ,Medicine ,SCRIB gene ,Cardiology and Cardiovascular Medicine ,business - Published
- 2012
26. Association of M235T polymorphism of angiotensinogen gene, ST2 level and lipid parameters in heart failure patients with type 2 diabetes mellitus
- Author
-
I. Rudyk, M. Udovychenko, and O Medentseva
- Subjects
medicine.medical_specialty ,Endocrinology ,business.industry ,Heart failure ,Internal medicine ,medicine ,Angiotensinogen gene ,Type 2 Diabetes Mellitus ,Cardiology and Cardiovascular Medicine ,medicine.disease ,business - Published
- 2018
27. Case of Thrombosis of Rare Localization in a Cancer Patient with Combined form of Thrombophilia
- Author
-
A, Vorobev, primary, A, Makatsaria, additional, V, Bitsadze, additional, N, Khamani, additional, and M, Udovychenko, additional
- Published
- 2017
- Full Text
- View/download PDF
28. The influence of bisoprolol on lipids metabolism in patients with heart failure and systolic dysfunction depending on beta1-adrenergic receptor gene polymorphism
- Author
-
M. Udovychenko and I. Rudyk
- Subjects
medicine.medical_specialty ,Adrenergic receptor ,business.industry ,Metabolism ,medicine.disease ,Endocrinology ,Bisoprolol ,Internal medicine ,Heart failure ,medicine ,Cardiology ,In patient ,Gene polymorphism ,Cardiology and Cardiovascular Medicine ,business ,medicine.drug - Published
- 2015
29. КОПРОЛІТИ ХРЯЩОВИХ РИБ ІЗ ПАЛЕОГЕНОВИХ ВІДКЛАДІВ КРИМУ
- Author
-
V. S. Dernov and M. M. Udovychenko
- Subjects
Paleontology ,Phosphorite ,engineering ,Cartilaginous fish ,%22">Fish ,engineering.material ,Trace fossil ,Cenozoic ,Glauconite ,Paleogene ,Geology - Abstract
First is a description of the Eocene fish coprolites Selachicoprus volgensis Khosatskyet Vialov of sections Ak-kaya and Prolom (Belogorsky region, Crimea). The data obtained are expanding information about trace fossils vertebrates Paleogene and justify their prospects further researches of Cenozoic deposits of Ukraine. Investigated two coprolites location in Belogorsk region of Crimea. The first of them is a career gap, which is located on the left bank district. Kuchuk Karasu, about 1 km south of the village Prolom and the second is near the village Bila Skelia (White Rock) on the right bank Biyuk-Karasu was open N.I. Udovychenko and luhansk paleontologists studied for over 20 years. Should be noted that maximum concentration remains of vertebrates, with whom coprolites are found, there is a layer 4 and bottom layer 6, which are composed greenish-brown sand, glauconite, calcareous concretions of small phosphorite, small grains mixed gravel and greenish-yellow calcareous clay, sandstone with very large admixture of glauconite, phosphorite concretions small. The presence of well-preserved coprolites indicates the existence of the bottom of the reservoir areas inviting waters, and the presence of dissolved phosphates, which are not allowed to chemically break down coprolites. Keywords: coprolites, Eocene, Oligocene, Crimea.
- Published
- 2014
30. [CURRENT ISSUES OF BETA-BLOCKERS USE IN THE MANAGEMENT OF COVID-19 (REVIEW)].
- Author
-
Udovychenko M and Rudyk I
- Subjects
- Adrenergic beta-Antagonists therapeutic use, Comorbidity, Humans, SARS-CoV-2, COVID-19, Pulmonary Embolism drug therapy
- Abstract
Over the past two decades, the world has witnessed severe acute respiratory syndrome CoV (SARS-CoV), an underlying serious diseases, with a high rate of mortality in patients with comorbidities. Taking into account the clinical features of pulmonary edema, septic shock, deep vein thrombosis and pulmonary embolism, it seems that the severe course of COVID-19 can manifest itself in the body as a sympathetic storm and, possibly, can underlie many of the pathological processes that occur with COVID-19. It is the regulation of the RAAS by the adrenergic system may be crucially important in the course of COVID-19. This article outlines the benefits of beta blockers use in patients with COVID-19 based on the results of recent clinical and epidemiological studies. It has been shown that treatment with beta-blockers in this group of patients can potentially prevent the development of the disease at the earliest stages, reducing morbidity and mortality, preventing or reducing the development of pulmonary embolism, acute respiratory distress syndrome, pulmonary edema and complications of septic shock, fatal rhythm disturbances, etc. Of course, the final conclusions are somewhat premature and further research is needed to assess the positive effects of various beta-blockers use in the treatment of COVID-19.
- Published
- 2021
31. Effects of metabolic syndrome on arterial function in different age groups: the Advanced Approach to Arterial Stiffness study.
- Author
-
Topouchian J, Labat C, Gautier S, Bäck M, Achimastos A, Blacher J, Cwynar M, de la Sierra A, Pall D, Fantin F, Farkas K, Garcia-Ortiz L, Hakobyan Z, Jankowski P, Jelakovic A, Kobalava Z, Konradi A, Kotovskaya Y, Kotsani M, Lazareva I, Litvin A, Milyagin V, Mintale I, Persson O, Ramos R, Rogoza A, Ryliskyte L, Scuteri A, Sirenko Y, Soulis G, Tasic N, Udovychenko M, Urazalina S, Wohlfahrt P, Zelveian P, Benetos A, and Asmar R
- Subjects
- Adult, Age Factors, Aged, Aged, 80 and over, Ankle Brachial Index, Blood Glucose metabolism, Blood Pressure, Case-Control Studies, Dyslipidemias physiopathology, Female, Humans, Lipoproteins, HDL blood, Male, Middle Aged, Obesity physiopathology, Prospective Studies, Pulse Wave Analysis, Triglycerides blood, Arteries physiopathology, Hyperglycemia physiopathology, Hypertension physiopathology, Metabolic Syndrome physiopathology, Vascular Stiffness
- Abstract
Objective: The aim of the Advanced Approach to Arterial Stiffness study was to compare arterial stiffness measured simultaneously with two different methods in different age groups of middle-aged and older adults with or without metabolic syndrome (MetS). The specific effects of the different MetS components on arterial stiffness were also studied., Methods: This prospective, multicentre, international study included 2224 patients aged 40 years and older, 1664 with and 560 without MetS. Patients were enrolled in 32 centres from 18 European countries affiliated to the International Society of Vascular Health & Aging. Arterial stiffness was evaluated using the cardio-ankle vascular index (CAVI) and the carotid-femoral pulse wave velocity (CF-PWV) in four prespecified age groups: 40-49, 50-59, 60-74, 75-90 years. In this report, we present the baseline data of this study., Results: Both CF-PWV and CAVI increased with age, with a higher correlation coefficient for CAVI (comparison of coefficients P < 0.001). Age-adjusted and sex-adjusted values of CF-PWV and CAVI were weakly intercorrelated (r = 0.06, P < 0.001). Age-adjusted and sex-adjusted values for CF-PWV but not CAVI were higher in presence of MetS (CF-PWV: 9.57 ± 0.06 vs. 8.65 ± 0.10, P < 0.001; CAVI: 8.34 ± 0.03 vs. 8.29 ± 0.04, P = 0.40; mean ± SEM; MetS vs. no MetS). The absence of an overall effect of MetS on CAVI was related to the heterogeneous effects of the components of MetS on this parameter: CAVI was positively associated with the high glycaemia and high blood pressure components, whereas lacked significant associations with the HDL and triglycerides components while exhibiting a negative association with the overweight component. In contrast, all five MetS components showed positive associations with CF-PWV., Conclusion: This large European multicentre study reveals a differential impact of MetS and age on CAVI and CF-PWV and suggests that age may have a more pronounced effect on CAVI, whereas MetS increases CF-PWV but not CAVI. This important finding may be due to heterogeneous effects of MetS components on CAVI. The clinical significance of these original results will be assessed during the longitudinal phase of the study.
- Published
- 2018
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.